GENFIT
Develops therapies and diagnostics for patients with rare and severe liver diseases.
GNFT | PA
Overview
Corporate Details
- ISIN(s):
- FR0004163111 (+2 more)
- LEI:
- 969500XPWN2DMZQA5X73
- Country:
- France
- Address:
- 885 AVENUE EUGENE AVINEE, 59120 LOOS
- Website:
- https://www.genfit.com
Description
GENFIT is a biopharmaceutical company dedicated to developing therapeutic and diagnostic solutions for patients with rare and severe liver diseases characterized by high unmet medical needs. The company's primary focus is on Acute-on-Chronic Liver Failure (ACLF) and its associated conditions, such as acute decompensation (AD) and hepatic encephalopathy (HE). Leveraging a scientific heritage of over two decades, GENFIT is a pioneer in liver disease research and development, aiming to improve the lives of patients with these life-threatening conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-11-18 22:15 |
GENFIT: FNIH NIMBLE Study Demonstrates NIS4® Technology’s Unique Performance in…
|
English | 185.7 KB | ||
| 2021-11-09 22:10 |
GENFIT Announces First Patient First Visit for the Evaluation of NTZ in Subject…
|
English | 183.0 KB | ||
| 2021-11-09 22:10 |
GENFIT : première consultation du premier patient pour l’évaluation de NTZ chez…
|
French | 146.0 KB | ||
| 2021-11-08 22:10 |
GENFIT: Third Quarter 2021 Financial Information
|
English | 149.1 KB | ||
| 2021-11-08 22:10 |
GENFIT : Information financière du troisième trimestre 2021
|
French | 188.2 KB | ||
| 2021-11-02 22:10 |
New Clinical Data on GENFIT’s Investigational Compound Elafibranor to be Presen…
|
English | 147.2 KB | ||
| 2021-11-02 22:10 |
GENFIT : Nouvelles données cliniques concernant son composé expérimental elafib…
|
French | 115.3 KB | ||
| 2021-09-29 22:10 |
Genfit : Résultats financiers du premier semestre 2021 et point sur les activit…
|
French | 434.9 KB | ||
| 2021-09-29 22:10 |
GENFIT Reports First Half-Year 2021 Financial Results and Provides Corporate Up…
|
English | 403.9 KB | ||
| 2021-09-29 22:00 |
Rapport d'activité et financier semestriel 2021
|
French | 1.6 MB | ||
| 2021-07-09 22:10 |
GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commer…
|
English | 199.1 KB | ||
| 2021-07-09 22:10 |
GENFIT : Bilan semestriel du contrat de liquidité contracté avec le Crédit Indu…
|
French | 239.5 KB | ||
| 2021-06-30 22:10 |
GENFIT: June 30, 2021 Annual Shareholders Meeting results
|
English | 98.7 KB | ||
| 2021-06-30 22:10 |
GENFIT : Résultats de l’Assemblée Générale Mixte du 30 juin 2021
|
French | 120.2 KB | ||
| 2021-06-24 22:10 |
GENFIT obtains non-dilutive financing of €11 million in the form of a State Gua…
|
English | 135.6 KB |
Automate Your Workflow. Get a real-time feed of all GENFIT filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GENFIT
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GENFIT via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-07-07 | N/A | Other | Buy | 5,300 | 19,488.10 EUR |
| 2023-07-06 | N/A | Other | Buy | 1,100 | 4,048.00 EUR |
| 2023-07-05 | N/A | Other | Buy | 10,000 | 37,061.00 EUR |
| 2023-07-03 | N/A | Other | Buy | 5,300 | 18,769.95 EUR |
Peer Companies
